IFI-P · Erucin Series

Specimen SS-F-TRP-385 // PUNGENT · IFI-P

Erucin Series IV-AG-A

Brassica nigra

Black Mustard

Tier IVErucin Series

Target Trait

3.2×

fold-change

Erucin TRPA1 agonist fold-change

Technical Specifications

SKU

SS-F-TRP-385

Genomic Edits

6

GC Content

46.7%

Construct Length

3,549 bp

Promoter System

Tissue-specific 2A11

Expression System

Agrobacterium-mediated T-DNA

Host Strain

EHA105

Receptor Target

TRPA1

IFI Score

320

Pathway Edits

  • GSTU20 (glutathione S-transferase) upregulation for glucoerucin biosynthesis and TRPA1-active erucin formation
  • MAM3 (methylthioalkylmalate synthase 3) overexpression for 4-methylthiobutyl glucosinolate chain elongation
  • CYP79F1 upregulation for long-chain aliphatic glucosinolate oxime synthesis from homomethionine
  • FMOGS-OX1-null allele introduction to prevent glucoerucin oxidation to sulforaphane-analog branch
  • TGG1 myrosinase optimization for glucoerucin hydrolysis and free erucin release kinetics
  • AOP2 suppression for erucin ITC pathway selectivity over gluconapin-forming branch

Key Interventions

MAM3/CYP79F1 chain-elongation pathway amplification for glucoerucin pool expansion in Brassica nigraFMOGS-OX1-null allele preserves glucoerucin in the reduced thioether form for selective erucin ITC formation via TGG1 myrosinaseErucin TRPA1 electrophilic agonism confirmed by IFI-P calcium-flux assay; erucin isothiocyanate targets TRPA1 Cys621 for covalent channel activationT-DNA binary vector 2A11 system validated for tissue-specific stable genomic integration

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
320
IFI-A
—
IFI-F
—

Use Case

Tier IV erucin-enriched Brassica platform for sulfurous-ITC flavor applications in mustard condiments, cooked brassica flavor development, and TRPA1-selective functional ingredient production where erucin's milder, less volatile profile relative to AITC is preferred for thermal stability in hot-processed food applications.

License

$3999 · Tier IV License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Pungent · IFI-PAll Modalities